Oceania Healthcare (OCA) Stock Overview
Owns and operates retirement villages and care centres in New Zealand. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
OCA Community Fair Values
Create NarrativeSee what 18 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Oceania Healthcare Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NZ$0.74 |
| 52 Week High | NZ$0.93 |
| 52 Week Low | NZ$0.62 |
| Beta | 0.61 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -1.33% |
| 3 Year Change | -2.63% |
| 5 Year Change | -51.63% |
| Change since IPO | -6.33% |
Recent News & Updates
Narrative Update • Jun 26
OCA: Revised Assumptions Will Temper Expectations While Supporting Steady Future Earnings
Analysts have revised their fair value estimate for Oceania Healthcare from about NZ$0.84 to around NZ$0.72. This reflects updates to the discount rate, revenue growth, profit margin and future P/E assumptions used in their valuation work.
Narrative Update • May 12
OCA: Higher Future P/E Assumptions Will Support A Stronger Share Outlook
Analysts have raised their NZ$ fair value estimate for Oceania Healthcare from NZ$0.88 to NZ$0.97, reflecting updated assumptions for the discount rate, revenue growth, profit margins and a higher future P/E multiple. Valuation Changes Fair Value: The NZ$ fair value estimate has risen from NZ$0.88 to NZ$0.97.Narrative Update • Apr 24
OCA: Firmer Margins And Revenue Outlook Will Support Higher Future Earnings
Analysts have maintained Oceania Healthcare's fair value estimate at NZ$0.84, with only minor adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions. These changes have not affected the overall price target level.Recent updates
Narrative Update • Jun 26
OCA: Revised Assumptions Will Temper Expectations While Supporting Steady Future Earnings
Analysts have revised their fair value estimate for Oceania Healthcare from about NZ$0.84 to around NZ$0.72. This reflects updates to the discount rate, revenue growth, profit margin and future P/E assumptions used in their valuation work.Narrative Update • May 12
OCA: Higher Future P/E Assumptions Will Support A Stronger Share Outlook
Analysts have raised their NZ$ fair value estimate for Oceania Healthcare from NZ$0.88 to NZ$0.97, reflecting updated assumptions for the discount rate, revenue growth, profit margins and a higher future P/E multiple. Valuation Changes Fair Value: The NZ$ fair value estimate has risen from NZ$0.88 to NZ$0.97.Narrative Update • Apr 24
OCA: Firmer Margins And Revenue Outlook Will Support Higher Future Earnings
Analysts have maintained Oceania Healthcare's fair value estimate at NZ$0.84, with only minor adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions. These changes have not affected the overall price target level.Narrative Update • Apr 08
OCA: Fair Value Will Depend On Firmer Margins And Revenue Outlook
Analysts have nudged their price target for Oceania Healthcare slightly lower to NZ$0.84, reflecting updated views on revenue growth assumptions, profit margins and the appropriate discount rate. Valuation Changes Fair Value: NZ$0.84 is unchanged, with the updated assumptions still pointing to the same indicative value.Narrative Update • Mar 25
OCA: Fair Value Will Depend On Slightly Firmer Future Profitability
Analysts have kept their NZ$0.84 fair value estimate for Oceania Healthcare steady. They cited only small tweaks to assumptions around revenue growth, profit margins, discount rate and future P/E that do not materially shift their overall price view.Narrative Update • Mar 09
OCA: Fair Value Will Rely On Slightly Higher Future Profitability
Analysts have maintained their NZ$0.84 price target for Oceania Healthcare, citing only small adjustments in their underlying assumptions for discount rate, revenue growth, profit margin and future P/E that did not materially affect their valuation view. Valuation Changes Fair Value: NZ$0.84 remains unchanged, indicating no shift in the overall valuation outcome.Narrative Update • Feb 23
OCA: Fair Value Will Rely On Slightly Higher Future Profitability
Analysts now set their NZ$0.84 price target for Oceania Healthcare based on slightly updated assumptions for the discount rate, revenue growth, profit margin and future P/E, which fine tune rather than overhaul their previous view. Valuation Changes Fair Value: The NZ$0.84 fair value estimate is unchanged, indicating that the updated inputs leave the overall valuation level intact.Narrative Update • Feb 09
OCA: Fair Value Will Rely On Slightly Higher Future Profitability
Analysts have maintained their fair value estimate for Oceania Healthcare at $0.84 per share. Small refinements to the discount rate, revenue growth, profit margin and future P/E assumptions are driving this narrative update, rather than a change in the headline price target.Narrative Update • Jan 25
OCA: Steady Fair Value Will Depend On Slightly Higher Profitability
Analysts have modestly adjusted their price view on Oceania Healthcare, keeping fair value around $0.84 while fine tuning assumptions on the discount rate, revenue growth, profit margin and future P/E to reflect slightly updated expectations for the business. Valuation Changes Fair Value: Fair value remains unchanged at NZ$0.84 per share, which suggests only fine tuning in the underlying assumptions rather than a shift in the overall valuation anchor.Narrative Update • Jan 10
OCA: Steady Fair Value Will Rely On Marginally Higher Profitability
Analysts have kept their price target for Oceania Healthcare broadly steady, with only a marginal adjustment that reflects slight changes in assumptions for revenue growth, profit margins and the future P/E multiple, rather than a shift in the overall view of the company. Valuation Changes Fair Value: Model fair value per share remains unchanged at NZ$0.84.Narrative Update • Dec 27
OCA: Slightly Lower Risk And Margins Will Support Fair Future Pricing
Analysts have slightly raised their price target on Oceania Healthcare to NZ$0.84, citing marginal improvements in assumed revenue growth, profit margins, and a modestly lower discount rate that together support a similar but incrementally more confident valuation profile. Valuation Changes Fair Value: Unchanged at NZ$0.84 per share, indicating a steady central valuation despite model refinements.Narrative Update • Dec 12
OCA: Lower Discount Rate Will Mask Weaker Revenue And Margin Outlook
Analysts have raised their fair value estimate for Oceania Healthcare from NZ$0.73 to NZ$0.84 per share, reflecting a slightly lower discount rate and higher expected future valuation multiples, even as they trim assumptions for revenue growth and profit margins. Valuation Changes The fair value estimate has risen moderately, from NZ$0.73 to NZ$0.84 per share.Analysis Article • Nov 28
Oceania Healthcare's (NZSE:OCA) Solid Earnings May Rest On Weak Foundations
The recent earnings posted by Oceania Healthcare Limited ( NZSE:OCA ) were solid, but the stock didn't move as much as...Analysis Article • Sep 05
Is Oceania Healthcare (NZSE:OCA) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Analysis Article • Jul 08
Further Upside For Oceania Healthcare Limited (NZSE:OCA) Shares Could Introduce Price Risks After 27% Bounce
The Oceania Healthcare Limited ( NZSE:OCA ) share price has done very well over the last month, posting an excellent...Analysis Article • May 29
Oceania Healthcare's (NZSE:OCA) Anemic Earnings Might Be Worse Than You Think
The subdued market reaction suggests that Oceania Healthcare Limited's ( NZSE:OCA ) recent earnings didn't contain any...New Narrative • May 09
Elmwood And Franklin Projects Will Improve Operational Efficiency
Strategic divestment and focus on modernized portfolio aim to enhance operational efficiency and profitability, positively impacting net margins.Analysis Article • Nov 26
Estimating The Intrinsic Value Of Oceania Healthcare Limited (NZSE:OCA)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Oceania Healthcare fair value estimate is NZ$0.81 Current...Analysis Article • Jul 22
Oceania Healthcare Limited (NZSE:OCA) Stock Rockets 31% But Many Are Still Ignoring The Company
Oceania Healthcare Limited ( NZSE:OCA ) shareholders would be excited to see that the share price has had a great...Analysis Article • Jun 20
Oceania Healthcare Limited's (NZSE:OCA) CEO Might Not Expect Shareholders To Be So Generous This Year
Key Insights Oceania Healthcare will host its Annual General Meeting on 27th of June CEO Brent Pattison's total...Analysis Article • May 31
Oceania Healthcare's (NZSE:OCA) Earnings Are Of Questionable Quality
Oceania Healthcare Limited ( NZSE:OCA ) announced strong profits, but the stock was stagnant. We did some digging, and...Analysis Article • May 18
Be Wary Of Oceania Healthcare (NZSE:OCA) And Its Returns On Capital
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...Analysis Article • Feb 22
Calculating The Fair Value Of Oceania Healthcare Limited (NZSE:OCA)
Key Insights Oceania Healthcare's estimated fair value is NZ$0.95 based on Dividend Discount Model Oceania Healthcare's...Analysis Article • Nov 26
Oceania Healthcare (NZSE:OCA) Is Paying Out Less In Dividends Than Last Year
The board of Oceania Healthcare Limited ( NZSE:OCA ) has announced that the dividend on 14th of December will be...Analysis Article • Aug 02
Oceania Healthcare Limited's (NZSE:OCA) Intrinsic Value Is Potentially 75% Above Its Share Price
Today we will run through one way of estimating the intrinsic value of Oceania Healthcare Limited ( NZSE:OCA ) by...Analysis Article • May 23
Oceania Healthcare (NZSE:OCA) Is Paying Out A Larger Dividend Than Last Year
Oceania Healthcare Limited ( NZSE:OCA ) will increase its dividend on the 21st of June to NZ$0.023, which is 9.5...Analysis Article • Jan 24
Calculating The Intrinsic Value Of Oceania Healthcare Limited (NZSE:OCA)
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Oceania Healthcare...Analysis Article • May 04
Factors Income Investors Should Consider Before Adding Oceania Healthcare Limited (NZSE:OCA) To Their Portfolio
Could Oceania Healthcare Limited ( NZSE:OCA ) be an attractive dividend share to own for the long haul? Investors are...Analysis Article • Mar 23
Oceania Healthcare Limited's (NZSE:OCA) Intrinsic Value Is Potentially 50% Above Its Share Price
Today we will run through one way of estimating the intrinsic value of Oceania Healthcare Limited ( NZSE:OCA ) by...Analysis Article • Feb 25
Does Oceania Healthcare (NZSE:OCA) Have A Healthy Balance Sheet?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analysis Article • Feb 04
It Might Not Be A Great Idea To Buy Oceania Healthcare Limited (NZSE:OCA) For Its Next Dividend
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...Analysis Article • Jan 17
If You Had Bought Oceania Healthcare (NZSE:OCA) Shares Three Years Ago You'd Have Earned 39% Returns
You can receive the average market return by buying a low-cost index fund. But you can make superior returns by picking...Analysis Article • Dec 27
Read This Before Buying Oceania Healthcare Limited (NZSE:OCA) For Its Dividend
Is Oceania Healthcare Limited ( NZSE:OCA ) a good dividend stock? How can we tell? Dividend paying companies with...Shareholder Returns
| OCA | NZ Healthcare | NZ Market | |
|---|---|---|---|
| 7D | -1.3% | 1.6% | 0.2% |
| 1Y | -1.3% | -33.2% | 5.7% |
Return vs Industry: OCA exceeded the NZ Healthcare industry which returned -33.2% over the past year.
Return vs Market: OCA underperformed the NZ Market which returned 5.7% over the past year.
Price Volatility
| OCA volatility | |
|---|---|
| OCA Average Weekly Movement | 5.4% |
| Healthcare Industry Average Movement | 5.1% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in NZ Market | 8.7% |
| 10% least volatile stocks in NZ Market | 2.7% |
Stable Share Price: OCA has not had significant price volatility in the past 3 months compared to the NZ market.
Volatility Over Time: OCA's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 2,246 | Suzanne Dvorak | oceaniahealthcare.co.nz |
Oceania Healthcare Limited, together with its subsidiaries, owns and operates retirement villages and care centres in New Zealand. The company operates through Care Operations, Village Operations, and Others segments. It provides traditional care beds and care suites; independent living and rental properties; and rest home, hospital, and specialist dementia services.
Oceania Healthcare Limited Fundamentals Summary
| OCA fundamental statistics | |
|---|---|
| Market cap | NZ$535.93m |
| Earnings (TTM) | NZ$119.00k |
| Revenue (TTM) | NZ$268.77m |
4,504x
P/E Ratio2.0x
P/S RatioIs OCA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OCA income statement (TTM) | |
|---|---|
| Revenue | NZ$268.77m |
| Cost of Revenue | NZ$191.48m |
| Gross Profit | NZ$77.29m |
| Other Expenses | NZ$77.17m |
| Earnings | NZ$119.00k |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Nov 30, 2026
| Earnings per share (EPS) | 0.00016 |
| Gross Margin | 28.76% |
| Net Profit Margin | 0.044% |
| Debt/Equity Ratio | 43.9% |
How did OCA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/13 22:49 |
| End of Day Share Price | 2026/07/13 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Oceania Healthcare Limited is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Stephen Ridgewell | Deutsche Bank |
| Will Twiss | Forsyth Barr Group Ltd. |
| Arie Dekker | Jarden Limited |